Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 308, Issue 9, Pages H1020-H1029
Publisher
American Physiological Society
Online
2015-02-28
DOI
10.1152/ajpheart.00465.2014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiac-Specific Overexpression of CYP2J2 Attenuates Diabetic Cardiomyopathy in Male Streptozotocin-Induced Diabetic Mice
- (2013) Ben Ma et al. ENDOCRINOLOGY
- Mechanisms of Chronic State of Inflammation as Mediators That Link Obese Adipose Tissue and Metabolic Syndrome
- (2013) Eduardo Fuentes et al. MEDIATORS OF INFLAMMATION
- Pharmacologic Prevention of Microvascular and Macrovascular Complications in Diabetes Mellitus
- (2012) Nikhil Tandon et al. American Journal of Cardiovascular Drugs
- Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats
- (2012) Kathleen Guglielmino et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health
- (2012) Christophe Morisseau et al. Annual Review of Pharmacology and Toxicology
- Epoxyeicosatrienoic Acids Contribute With Altered Nitric Oxide and Endothelin-1 Pathways to Conduit Artery Endothelial Dysfunction in Essential Hypertension
- (2012) Jeremy Bellien et al. CIRCULATION
- Inhibition of Soluble Epoxide Hydrolase Attenuates High-Fat-Diet–Induced Hepatic Steatosis by Reduced Systemic Inflammatory Status in Mice
- (2012) Yan Liu et al. PLoS One
- Arteriogenic Therapy by Intramyocardial Sustained Delivery of a Novel Growth Factor Combination Prevents Chronic Heart Failure
- (2011) Sébastien Banquet et al. CIRCULATION
- Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Diet-Induced Metabolic Syndrome in Rats
- (2011) Abishek Iyer et al. Experimental Diabetes Research
- Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension
- (2011) Ji Gao et al. JOURNAL OF HYPERTENSION
- Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure
- (2011) Nassiba Merabet et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: A promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?
- (2011) Jeremy Bellien et al. PHARMACOLOGY & THERAPEUTICS
- Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance
- (2011) A. Luria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased CYP2J3 Expression Reduces Insulin Resistance in Fructose-Treated Rats and db/db Mice
- (2010) X. Xu et al. DIABETES
- Cardiovascular Disease in Type 2 Diabetes From Population to Man to Mechanisms: The Kelly West Award Lecture 2008
- (2010) M. Laakso DIABETES CARE
- Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension
- (2010) Le-Ning Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibition or Deletion of Soluble Epoxide Hydrolase Prevents Hyperglycemia, Promotes Insulin Secretion, and Reduces Islet Apoptosis
- (2010) P. Luo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Inhibition of soluble epoxide hydrolase reduces food intake and increases metabolic rate in obese mice
- (2010) J.M. do Carmo et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications
- (2010) Corey E. Tabit et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Diabetic cardiomyopathy, causes and effects
- (2010) Sihem Boudina et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Expression and Regulation of Soluble Epoxide Hydrolase in Adipose Tissue
- (2009) Bart M. De Taeye et al. Obesity
- Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
- (2008) Theodore Mazzone et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started